Insights from Digital Pharma Leaders
Refine Search
Pharmaceutical
The use of digital health technologies has grown rapidly over the last couple of years – accelerating even more during the COVID-19 pandemic. As digital health continues to hold an important place in modern healthcare, it is critical to ensure the safety of digital health devices and applications. Regulation of these devices by the US Food and Drug Administration (FDA) is fundamental to achieving this goal. 15 February 2021
Pharmaceutical
The pharmaceutical industry is now frequently the number one target of cybercriminals around the world, as drugmakers move toward increased digitization and storing valuable data online. 9 February 2021
Biotechnology
AstraZeneca has selected a novel chronic kidney disease (CKD) target to advance to its drug development portfolio, under its collaboration with fellow UK-based artificial intelligence (AI) company BenevolentAI. 28 January 2021
Pharmaceutical
Novartis’ Steven Baert, chief people and organization officer, and Elizabeth Theophille, chief technology transformation officer, provide an Expert View predicting what will dictate developments in the pharmaceutical and healthcare industries in 2021. 19 January 2021
Biotechnology
Research from industry analyst GlobalData has found that established players in Japan’s immunology market have a dominant lead in the digital marketing space. 15 December 2020
Pharmaceutical
The European pharmaceutical industry has thrown its weight behind the use of artificial intelligence (AI) in drug development, with the publication of a new paper advocating its use. 3 December 2020
Biotechnology
British artificial intelligence specialist InstaDeep and German biotech firm BioNTech have deepened ties, embarking on a multi-year project to develop new technologies. 25 November 2020
Pharmaceutical
COVID-19 has led pharma companies to rethink their operations and customer access, says GlobalData research. 11 November 2020
Biotechnology
insitro, a California-based machine-learning driven drug discovery and development company, has entered into a five-year, discovery collaboration with US pharma major Bristol Myers Squibb focused on the discovery and development of novel therapies for the treatment of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). 29 October 2020
Pharmaceutical
An Expert View from Karen Noonan at the Association of Clinical Research Organizations (ACRO) on adopting a more flexible approach to trials moving forward, something made all the more important by the COVID-19 pandemic. 28 September 2020
Pharmaceutical
One of the sectors that has shown its worth and grown during the pandemic has been digital technology. 18 September 2020
Pharmaceutical
At the annual congress of the European Society of Medical Oncology (ESMO), taking place virtually, Johnson & Johnson’s pharma arm Janssen hopes to raise the bar with quality of life data for Erleada (apalutamide). 17 September 2020
Pharmaceutical
US tech-based therapy firm Click Therapeutics has notched up another big pharma partner, as its joins with Germany’s Boehringer Ingelheim for the development and commercialization of a prescription-based digital therapeutic. 11 September 2020
Biotechnology
Germany’s Bayer and USA-based Recursion Pharmaceuticals, a digital biology company industrializing drug discovery, have entered into a strategic collaboration. 9 September 2020
Biotechnology
German pharma major Bayer has strengthened its ties with the USA-based digital health platform Informed Data Systems. 24 August 2020
Pharmaceutical
Pierre-Georges Roy, partner at M&A advisor Results International, provides an Expert View on why deals kept being made even as much of society shut down. 18 August 2020
Pharmaceutical
Developments in artificial intelligence (AI) and machine learning (ML) are playing an increasingly influential role in the biotech space, driving the formation of new partnerships ,between the tech and healthcare industries. 3 August 2020
Pharmaceutical
Artificial intelligence specialist Healx has launched a partnership with Muscular Dystrophy UK (MDUK) to find novel therapies for facioscapulohumeral muscular dystrophy (FSHD). 15 July 2020
Biotechnology
French immunotherapy specialist Transgene has hailed as a “world premiere” a blockchain-based solution for clinical trials. 9 July 2020
Pharmaceutical
Akili, a funded entity of London-listed biotech firm PureTech Health, today announced that it has received a Conformité Européenne (CE) Mark for EndeavorRx (AKL-T01) as a prescription-only digital therapeutic software intended for the treatment of attention and inhibitory control deficits in pediatric patients with attention deficit hyperactivity disorder (ADHD). 23 June 2020
Biotechnology
This week, we discuss a novel AI-driven approach to drug development, and its potential to transform the treatment of cancer and autoimmune diseases. 14 November 2024
Pharmaceutical
Digital therapeutics company GAIA has announced the signing of a licensing agreement for attexis with fellow German firm MEDICE Arzneimittel Pütter. 14 November 2024
Biotechnology
Privately-held Boston-based biopharma FogPharma has announced a name change and unveiled a new AI-based platform. 11 November 2024
Pharmaceutical
A review has found that complexities and inefficiencies within the UK’s health data infrastructure are hindering the effective use of these resources that are critical for improving people’s health. 8 November 2024
Pharmaceutical
An Expert View from Nick Petschek, Managing Director EMEA, Kotter International. 18 October 2024
Pharmaceutical
California-based AI company Suki has raised $70 million in new funding to accelerate the growth of its AI-powered voice solutions in healthcare. 11 October 2024
Pharmaceutical
Machine learning-enabled drug discovery and development company insitro has announced the execution of three strategic agreements with Eli Lilly. 10 October 2024
Biotechnology
China’s Quantum Pharmaceuticals has announced a significant licensing agreement between its biologics-focused subsidiary, Ailux Biologics, and Johnson & Johnson. 10 October 2024
Pharmaceutical
The UK has launched a new Regulatory Innovation Office (RIO), with the goal of accelerating new technologies, particularly in sectors like biotech and healthcare, by reducing regulatory barriers. 9 October 2024
Biotechnology
British biotech IMU Biosciences has announced key changes to its leadership team as it looks to grow in the field of precision medicine. 17 September 2024
Biotechnology
Californian companies Gilead Sciences and Genesis Therapeutics have entered into a strategic collaboration to discover and develop novel, small molecule therapies across multiple targets. 10 September 2024
Biotechnology
ZipBio, a newly launched start-up based in Seattle, USA, is aiming to set a new standard in the development of biologics and gene therapies by utilizing generative AI technology. 9 September 2024
Pharmaceutical
An Expert View from Vikas Krishan, chief digital business officer at Altimetrik. 4 September 2024
Pharmaceutical
Otsuka Pharmaceuticals says that its subsidiaries Otsuka Precision Health, Inc. (OPH) and Click Therapeutics (Click) have launched Rejoyn (developed as CT-152). 19 August 2024
Pharmaceutical
CytoReason’s $80 million venture round may not have been the biggest in July, but it is one of a growing number of investor bets on AI powered drug discovery this year. 7 August 2024
Pharmaceutical
California’s ReviR Therapeutics has completed a $30 million series A financing round, bringing its total funding to $54 million. 29 July 2024
Pharmaceutical
An Expert View from Brendan Frey, founder and chief innovation officer of Deep Genomics. 4 July 2024
Biotechnology
AI-focused start-up Formation Bio has raised $372 million in a series D financing. 27 June 2024
Pharmaceutical
A recent survey from IDC highlights that 49% of the pharmaceutical industry believes they have achieved success in implementing artificial intelligence (AI) across the entire pharmacovigilance (PV) value chain. However, over the next two years, the industry expects this number to only marginally shift to just 51%. 17 June 2024
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze